Retraction

Effect of integrin receptor‑targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy

Paper Information

Record ID:
26512
Author(s):
Liyu Chen
Yanbin Liu
Weiya Wang
Kai Liu
Journal:
Oncology Letters ( Spandidos )
Publication Date:
May 20, 2015
Retraction Date:
March 04, 2021 (4.7 years years ago)
Subjects:
Broad Categories:
Genetics Biology Biochemistry
Institutions:
Country:
🇨🇳 China
Article Type:
Research Article
Publisher:
Spandidos
Open Access:
Yes
DOI:
10.3892/ol.2015.3242
PubMed ID:
26170980
Retraction PubMed ID:
33747207

Retraction Details

Retraction Reasons:
Nature of Retraction:

Retraction

Retraction Notice:
10.3892/ol.2021.12611
Additional Notes:

see also: https://pubpeer.com/publications/93466560B8B4C5E737A9F93F8E06D8;

Citations (43)

43
Total Citations
10
Post-Retraction
(23.3%)
33
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
3 Within 1 year
4 After 2+ years
1273 Days since retraction (latest)
Tibetan tea extract exerts anti-tumor effects and potentiate paclitaxel-induced cytotoxicity and apoptosis in human hepatocellular carcinoma cells HepG2
Lang He, Guanghong Wang, Siwei Deng et al. (8 authors)
South African Journal of Botany
Published: Aug 2024
1 citation
1273 days after retraction
Construction and evaluation of liposomal drug delivery system for an ALK/HDACs dual-targeted inhibitor with sustained release and enhanced antitumor effect
Fang Ren, Zongjie Gan, Qianyu Zhang et al. (11 authors)
Drug Delivery and Translational Research
Published: Aug 2024
2 citations
1252 days after retraction
c(RGDfK) anchored surface manipulated liposome for tumor-targeted tyrosine kinase inhibitor (TKI) delivery to potentiate liver anticancer activity
Payal Deepak, Praveen Kumar, Dilip Kumar Arya et al. (9 authors)
International Journal of Pharmaceutics
Published: Jun 2023
19 citations
844 days after retraction
Paper citing Effect of integrin receptor‑targeted liposomal pac...
Unknown Authors
Unknown Journal
Published: Mar 2023
749 days after retraction
Potential Application of Small Interfering RNA in Gastro-Intestinal Tumors
Pasquale Losurdo, Nicolò de Manzini, Silvia Palmisano et al. (11 authors)
Pharmaceuticals Open Access
Published: Oct 2022
5 citations
595 days after retraction
Theranostics Usage of Nano Drug Complexes in Clinical Patientcare
Taha Nazir, Saeed Ur Rashid Nazir, Humayun Riaz et al. (11 authors)
Journal of Pharmaceutical Research International Open Access
Published: Aug 2022
545 days after retraction
Ya'an Tibetan Tea Exerts Anti-tumor and Chemotherapy Sensitizing Effect against Human HepG2 Hepatocellular Carcinoma Cells
Lang He, Yang Yu, Siwei Deng et al. (10 authors)
Research Square (Research Square) Open Access
Published: Mar 2022
1 citation
383 days after retraction
Gelatin Coating for the Improvement of Stability and Cell Uptake of Hydrophobic Drug-Containing Liposomes
Gantumur Battogtokh, Yechan Joo, S. ABUZAR et al. (5 authors)
Molecules Open Access
Published: Feb 2022
31 citations
336 days after retraction
Glimpse into the Cellular Internalization and Intracellular Trafficking of Lipid- Based Nanoparticles in Cancer Cells
Gholamreza Dehghan, Behzad Baradaran, Elham Kazemi et al. (8 authors)
Anti-Cancer Agents in Medicinal Chemistry
Published: Sep 2021
5 citations
187 days after retraction
An update on actively targeted liposomes in advanced drug delivery to glioma
Solmaz Mojarad-Jabali, Masoud Farshbaf, Paul R. Walker et al. (8 authors)
International Journal of Pharmaceutics
Published: Apr 2021
95 citations
54 days after retraction
Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways
Liang Yu, Meng Wang, Yang Yang et al. (8 authors)
PLoS Computational Biology Open Access
Published: Feb 2021
60 citations
23 days before retraction
Nanotechnology Based Approach for Hepatocellular Carcinoma Targeting
Abdulsalam Alhalmi, Sarwar Beg, Kanchan Kohli et al. (5 authors)
Current Drug Targets
Published: Dec 2020
24 citations
83 days before retraction
Surface receptor‐mediated targeted drug delivery systems for enhanced cancer treatment: A state‐of‐the‐art review
Selvaraj Kunjiappan, Parasuraman Pavadai, Vellaichamy Sivakumar et al. (11 authors)
Drug Development Research
Published: Nov 2020
67 citations
114 days before retraction
RGD peptide-mediated liposomal curcumin targeted delivery to breast cancer cells
Reza Mahmoudi, Seyedeh Ashraf Mirahmadi-Babaheidri, Hamdollah Delaviz et al. (8 authors)
Journal of Biomaterials Applications
Published: Aug 2020
65 citations
199 days before retraction
Gene Therapy for Hepatocellular Carcinoma: Highlighting the Journey from Theory to Clinical Applications
Mahmoud A. Younis, Ikramy A. Khalil, Hideyoshi Harashima
Advanced Therapeutics
Published: Aug 2020
24 citations
203 days before retraction
c(RGDfK)‐ and ZnTriMPyP‐Bound Polymeric Nanocarriers for Tumor‐Targeted Photodynamic Therapy
Elena de las Heras, Ester Boix‐Garriga, Francesca Bryden et al. (9 authors)
Photochemistry and Photobiology
Published: Feb 2020
1 citation
371 days before retraction
Nanocarrier-mediated antioxidant delivery for liver diseases
Senlin Li, Huiru Li, Xiaoding Xu et al. (5 authors)
Theranostics Open Access
Published: Jan 2020
61 citations
428 days before retraction
<p>Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity</p>
Bing Han, Yue Yang, Jinglin Chen et al. (18 authors)
International Journal of Nanomedicine Open Access
Published: Jan 2020
73 citations
428 days before retraction
The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
Ling Wei, Xingwu Wang, Liyan Lv et al. (10 authors)
Molecular Cancer Open Access
Published: Oct 2019
298 citations
496 days before retraction
ApoE-modified liposomes mediate the antitumour effect of survivin promoter-driven HSVtk in hepatocellular carcinoma
Xiuli Mu, Xi Wang, Wei Yan et al. (20 authors)
Cancer Gene Therapy Open Access
Published: Oct 2019
13 citations
498 days before retraction
Paclitaxel nanocrystalline assemblies as a potential transcatheter arterial chemoembolization (TACE) candidate for unresectable hepatocellular carcinoma
Atul Dev, Ankur Sood, Subhasree Roy Choudhury et al. (4 authors)
Materials Science and Engineering C
Published: Oct 2019
15 citations
504 days before retraction
Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma
Muhammed H. Elnaggar, Abdelrahman Ibrahim Abushouk, Ahmed H.E. Hassan et al. (12 authors)
Seminars in Cancer Biology
Published: Aug 2019
48 citations
568 days before retraction
The enhancing effect of N-acetylcysteine modified hyaluronic acid-octadecylamine micelles on the oral absorption of paclitaxel
Mei Zhang, Sajid Asghar, Xin Jin et al. (8 authors)
International Journal of Biological Macromolecules
Published: Jul 2019
26 citations
593 days before retraction
Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy
Yongbing Sun, Wen Ma, Yuanyuan Yang et al. (8 authors)
Asian Journal of Pharmaceutical Sciences Open Access
Published: Jun 2019
108 citations
631 days before retraction
Multifunctional nanocarriers based on graphitic-C<sub>3</sub>N<sub>4</sub> quantum dots for tumor-targeted, traceable and pH-responsive drug delivery
Wenxian Zhang, Jian Dong, Guangyao Dang et al. (10 authors)
New Journal of Chemistry
Published: Jan 2019
7 citations
793 days before retraction
Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma
Primiano Pio Di Mauro, Anna Cascante, Pau Brugada Vilà et al. (6 authors)
International Journal of Pharmaceutics
Published: Oct 2018
30 citations
874 days before retraction
Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer
Anne Rodallec, Jean Michel Brunel, Sarah Giacometti et al. (12 authors)
International Journal of Nanomedicine Open Access
Published: Jun 2018
42 citations
1007 days before retraction
Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and Effectiveness
Rossella Farra, Francesco Musiani, Francesca Perrone et al. (23 authors)
Molecules Open Access
Published: Mar 2018
22 citations
1072 days before retraction
Magnetic Resonance Gd-RGD Imaging Study of Hepatocellular Carcinoma with High and Low Metastatic Potential before and after Human Bone Marrow-derived Mesenchymal Stem Cell Intervention
Tianran Li, Minghui Yu, Xiaobin Huang et al. (6 authors)
Chinese Medical Journal Open Access
Published: Oct 2017
3 citations
1227 days before retraction
Glycyrrhetinic Acid Liposomes Containing Mannose-Diester Lauric Diacid-Cholesterol Conjugate Synthesized by Lipase-Catalytic Acylation for Liver-Specific Delivery
Jing Chen, Yuchao Chen, Yi Cheng et al. (4 authors)
Molecules Open Access
Published: Sep 2017
18 citations
1257 days before retraction
Evaluation of pharmacokinetic and pharmacodynamic profiles of liposomes for the cell type-specific delivery of small molecule drugs
Siva Sai Krishna Dasa, Ryo Suzuki, Emily Mugler et al. (10 authors)
Nanomedicine Nanotechnology Biology and Medicine Open Access
Published: Jul 2017
13 citations
1318 days before retraction
RGD-Modified Albumin Nanoconjugates for Targeted Delivery of a Porphyrin Photosensitizer
Fang Li, Yan Zhao, Chengqiong Mao et al. (5 authors)
Molecular Pharmaceutics Open Access
Published: Jul 2017
55 citations
1331 days before retraction
Recent advances in hepatocellular carcinoma therapy
Rinku Dutta, Ram I. Mahato
Pharmacology & Therapeutics Open Access
Published: Feb 2017
255 citations
1488 days before retraction
Advances in tumor-targeted therapy using nanomedicine.
Divya Karukonda
Unknown Journal Open Access
Published: Jan 2017
1523 days before retraction
Predicting therapeutic and aggravating drugs for hepatocellular carcinoma based on tissue-specific pathways
Liang Yu, Fengdan Xu, Lin Gao
arXiv (Cornell University) Open Access
Published: Jan 2017
1 citation
1523 days before retraction
Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma
Sandhya Pranatharthiharan, Mitesh D. Patel, Vinod C. Malshe et al. (8 authors)
Drug Delivery Open Access
Published: Jan 2017
91 citations
1523 days before retraction
ATF2 translation is induced under chemotherapeutic drug-mediated cellular stress via an IRES-dependent mechanism in human hepatic cancer Bel7402 cells
Qi Li, Wenqing Gao, Wenyan Dai et al. (6 authors)
Oncology Letters Open Access
Published: Oct 2016
8 citations
1598 days before retraction
Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma
Min Li, Weiyue Zhang, Birong Wang et al. (6 authors)
International Journal of Nanomedicine Open Access
Published: Oct 2016
128 citations
1615 days before retraction
Screening and identification of a specific peptide for targeting hypoxic hepatoma cells
Yiming Liu, Xiangwen Xia, Yong Wang et al. (8 authors)
Molecular and Cellular Probes
Published: Jul 2016
3 citations
1705 days before retraction
Alpha fetoprotein antagonizes apoptosis induced by paclitaxel in hepatoma cells in vitro
Mingyue Zhu, Wei Li, Yan Lu et al. (9 authors)
Scientific Reports Open Access
Published: Jun 2016
32 citations
1735 days before retraction
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy
Ewelina Piktel, Katarzyna Niemirowicz, Marzena Wątek et al. (6 authors)
Journal of Nanobiotechnology Open Access
Published: May 2016
158 citations
1743 days before retraction
Effect of Combined Treatment Using Wilfortrine and Paclitaxel in Liver Cancer and Related Mechanism
Shuzhen Li, Lei Zheng
Medical Science Monitor Open Access
Published: Apr 2016
7 citations
1795 days before retraction
A review of the ligands and related targeting strategies for active targeting of paclitaxel to tumours
Juan Li, Fengshan Wang, Deqing Sun et al. (4 authors)
Journal of drug targeting
Published: Feb 2016
42 citations
1844 days before retraction
Quick Stats
Total Citations: 43
Years Since Retraction: 4.7 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesi…
Cancer Cell • 1307 citations
Divergent molecular profile of PIK3CA gene in arsenic-assoc…
Mutagenesis • 6 citations
Nestin suppression attenuates invasive potential of endomet…
Oncotarget • 17 citations
Suppression of uPA and uPAR Attenuates Angiogenin Mediated …
PLoS One • 39 citations
A Genetic Defect in Exportin-5 Traps Precursor MicroRNAs in…
Cancer Cell • 289 citations
Actions
More from this journal Similar subjects View Original Paper View Retraction Notice